FIELD: medicine.
SUBSTANCE: invention can be used in magnetic resonance imaging (MRI). The use of 1,2-bis(perfluoro-tert-butoxy)ethane as a contrast agent for magnetic resonance imaging on 19F nuclei has been proposed.
EFFECT: invention provides an expansion of the range of MPT contrast agents with a clearance rate of approximately 45 days.
1 cl, 4 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF 1,3-BIS(PERFLUORO-TERT-BUTYL)PROPANE AS A CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING ON F NUCLEI | 2022 |
|
RU2785791C1 |
| PHYSIOLOGICALLY ACCEPTABLE EMULSIONS CONTAINING PERFLUOROHYDROCARBON ETHER HYDRIDES AND METHODS FOR UTILIZATION THEREOF | 1995 |
|
RU2159610C2 |
| ELIMINATION OF INVOLVEMENT OF CONTRAST AGENT CONCENTRATION IN MRT | 2007 |
|
RU2446829C2 |
| CONTRAST AGENT FOR INTRODUCTION OF FLUORINE-19 LABEL INTO PROTEINS CONTAINING LYSINE RESIDUES | 2015 |
|
RU2599500C1 |
| SEMIFLUOROCARBON COMPOUND CONTAINING CONTRAST AGENT | 2014 |
|
RU2672588C2 |
| PERFLUOROALKYL-CONTAINING COMPLEXES WITH POLAR RESIDUES, METHOD FOR THEIR PREPARING, PHARMACEUTICAL AGENT | 2001 |
|
RU2289579C2 |
| COMPOSITION FOR APPLICATION IN PHOTODYNAMIC THERAPY OF CANCER | 2016 |
|
RU2626600C1 |
| METHOD OF TARGETED TRANSPORT OF BIOLOGICALLY ACTIVE SUBSTANCES AND APPLICATION OF STEM CELLS FOR TARGETED TRANSPORT | 2009 |
|
RU2426785C1 |
| DRUG CARRIER FOR CONTRAST ENHANCEMENT IN MRT | 2009 |
|
RU2528104C2 |
| BIOCOMPATIBLE CONTRASTING AGENT, STABLE BIOCOMPATIBLE COLLOIDAL DISPERSION, METHOD OF PREPARING ULTRASONIC IMAGE OF ANIMAL, METHODS OF PREPARING CONTRASTING AGENT STABLE IN STORAGE | 1994 |
|
RU2131744C1 |
